Cite
HARVARD Citation
Burmester, G. et al. (2018). Mavrilimumab, a Fully Human Granulocyte–Macrophage Colony‐Stimulating Factor Receptor α Monoclonal Antibody. Arthritis & rheumatology. 70 (5), pp. 679-689. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Burmester, G. et al. (2018). Mavrilimumab, a Fully Human Granulocyte–Macrophage Colony‐Stimulating Factor Receptor α Monoclonal Antibody. Arthritis & rheumatology. 70 (5), pp. 679-689. [Online].